Pivotal phase III trial launched in recurrent ovarian cancer
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined…
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer...